In 2023, a special report was published detailing the results of the Wessex AHSN FeNO Programme in England. The headline statistics were impressive. Thanks to the programme, 58,000 new asthmatics were diagnosed, more than 1,200 additional FeNO testing devices became available to primary care patients, 53% of primary care networks in England had access to FeNO testing as a result and almost 5,000 hours of training were completed over the two-year effort. This episode, we’re looking at the programme and asking: could this success go global? 

Did you know the world’s first FeNO testing machine was developed by the team behind NIOX®? It was 1.5m tall and 70cm wide! Our cutting-edge technology has come a long way since then. So this time, here’s a little about the story of the FeNO evolution. 

Fractional exhaled nitric oxide, known as FeNO, testing and spirometry can make a valuable pairing in asthma care. In this episode, we’re looking at how these two pieces of the respiratory puzzle can help to complete the picture.

Testing a patient’s level of fractional exhaled nitric oxide, known as FeNO, is a valuable tool in asthma diagnosis and management so it’s important to know you can rely on the results.1 In this episode, we’re explaining how FeNO testing with NIOX® makes it possible.

We spoke to FeNO expert Professor Kjell Alving about the science behind foods that affect a patient’s level of fractional exhaled nitric oxide, or FeNO. There’s more to it than meets the eye so let’s get started.

As athletes strive to achieve their goals, one area of increasing focus is the role of respiratory health in sports performance. Studies show that FeNO testing is one of the tools that can help. FeNO isn’t just for elite performers either. The role of FeNO in the management of daily exercise-induced problems among school children has also been examined. Today, we’re talking about some of the highlights.

Research has shown that cigarette smoking can reduce fractional exhaled nitric oxide – or FeNO – by around 60%1but what about vaping? Electronic or ‘e-cigarettes’ have gained significant popularity in recent years as an alternative to traditional tobacco smoking. However, concerns have been raised regarding the potential impact on public health. One aspect of particular interest to the respiratory community is whether vaping affects FeNO levels. In this episode, we explore the evidence.

Devices that measure FeNO have markedly influenced the clinical decision-making of healthcare professionals and helped alter treatment plans for patients with asthma. However, true accuracy and reproducibility of the results depend on various factors, including the proper use of the FeNO testing device. In this episode, we discuss the value of audio guides as part of this process.

This month marks 25 years of FeNO testing by NIOX®, a company founded by the same scientists who originally discovered its benefits in asthma care.

To mark World Asthma Day, in this episode our lead nurse for education and support, Karen Frankland, talks to broadcaster Will Luscombe to discuss how asthma treatment can be enhanced with the help of FeNO testing.